tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Amplia Therapeutics Secures Key US Patent for Cancer Drug Narmafotinib
Company AnnouncementsAmplia Therapeutics Secures Key US Patent for Cancer Drug Narmafotinib
10h ago
Amplia Therapeutics Announces Director’s Interest Changes
PremiumCompany Announcements
Amplia Therapeutics Announces Director’s Interest Changes
22d ago
Amplia Therapeutics Updates Director’s Interest Notice
PremiumCompany Announcements
Amplia Therapeutics Updates Director’s Interest Notice
22d ago
Amplia Therapeutics Updates Director’s Interest Notice
PremiumCompany Announcements
Amplia Therapeutics Updates Director’s Interest Notice
22d ago
Amplia Therapeutics Updates Director’s Interest Notice
PremiumCompany Announcements
Amplia Therapeutics Updates Director’s Interest Notice
22d ago
Amplia Therapeutics Announces Cessation of Securities
PremiumCompany AnnouncementsAmplia Therapeutics Announces Cessation of Securities
22d ago
Amplia Therapeutics Begins New Pancreatic Cancer Trial with First Patient Dosed
Premium
Company Announcements
Amplia Therapeutics Begins New Pancreatic Cancer Trial with First Patient Dosed
26d ago
Amplia Therapeutics Announces Cessation of Securities
Premium
Company Announcements
Amplia Therapeutics Announces Cessation of Securities
28d ago
Amplia Therapeutics’ FAK Inhibitor Gains USAN Approval
PremiumCompany Announcements
Amplia Therapeutics’ FAK Inhibitor Gains USAN Approval
28d ago
Amplia Therapeutics Issues New Unquoted Equity Securities
PremiumCompany Announcements
Amplia Therapeutics Issues New Unquoted Equity Securities
29d ago
Amplia Therapeutics Advances Cancer Treatment with Successful Capital Raise
PremiumCompany Announcements
Amplia Therapeutics Advances Cancer Treatment with Successful Capital Raise
29d ago
Amplia Therapeutics Announces Quotation of New Securities on ASX
PremiumCompany Announcements
Amplia Therapeutics Announces Quotation of New Securities on ASX
29d ago
Amplia Therapeutics Announces Quotation of New Securities on ASX
PremiumCompany AnnouncementsAmplia Therapeutics Announces Quotation of New Securities on ASX
29d ago
Amplia Therapeutics Launches New Pancreatic Cancer Trial in Australia
Premium
Company Announcements
Amplia Therapeutics Launches New Pancreatic Cancer Trial in Australia
1M ago
Amplia Therapeutics Advances Cancer Treatment with Successful AGM Resolutions
Premium
Company Announcements
Amplia Therapeutics Advances Cancer Treatment with Successful AGM Resolutions
1M ago
Amplia Therapeutics Advances FAK Inhibitor in Pancreatic Cancer Trials
PremiumCompany Announcements
Amplia Therapeutics Advances FAK Inhibitor in Pancreatic Cancer Trials
1M ago
Amplia Therapeutics Targets Pancreatic Cancer with Innovative FAK Inhibitors
PremiumCompany Announcements
Amplia Therapeutics Targets Pancreatic Cancer with Innovative FAK Inhibitors
2M ago
Amplia Therapeutics Reports Promising Interim Results from ACCENT Trial
PremiumCompany Announcements
Amplia Therapeutics Reports Promising Interim Results from ACCENT Trial
2M ago
Amplia Therapeutics Launches Share Purchase Plan to Raise Capital
PremiumCompany Announcements
Amplia Therapeutics Launches Share Purchase Plan to Raise Capital
2M ago
Amplia Therapeutics Relocates Headquarters to Melbourne
PremiumCompany AnnouncementsAmplia Therapeutics Relocates Headquarters to Melbourne
2M ago
Amplia Therapeutics Advances Cancer Treatment Trials and Secures Funding
Premium
Company Announcements
Amplia Therapeutics Advances Cancer Treatment Trials and Secures Funding
2M ago
Amplia Therapeutics Gains Ethics Approval for Pancreatic Cancer Trial
Premium
Company Announcements
Amplia Therapeutics Gains Ethics Approval for Pancreatic Cancer Trial
2M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >